07.25.25 -- Peeling Back The Layers Of Radiolabeled Peptide Production

Discover key considerations for qualifying GMP raw materials in CGT manufacturing, emphasizing quality control, supplier selection, and regulatory compliance to ensure therapeutic safety and efficacy.

Learn more about how these tools are vital to scientific progress to preserve samples, support experiments, and ensure the integrity of life-saving research in every modern laboratory.

While barrier films in bags can be useful for cold chain applications, they do not fully protect against gas ingress and ignore other sources of permeability.

Delve into the intricacies of ADC production and learn how cutting-edge technologies are being deployed to overcome these hurdles to bring life-saving treatments to patients.

In the biopharmaceutical development world, Quality by Design cuts risk, streamlines processes, and speeds up regulatory approval.

Learn actionable strategies that can lead to higher success rates and smarter resource investment, paving the way for a successful path to IND submissions and commercialization.

As the biologic patent cliff looms, biosimilar developers must strategically plot their approach to development and manufacturing to secure a corner of their market and reach their target patients.

High-quality process development aims to maintain a consistent process from toxicology through to GMP production runs, and can be aided by a capable, adaptable CDMO.

In this presentation, industry-leading bioprocess experts explore the challenges and opportunities that arise when implementing Quality by Design (QbD) in biologics development and manufacturing.

Start your forced degradation studies early to uncover molecular risks, strengthen product stability, and ensure regulatory-ready development from the start.

In the pursuit of making your mAb process as efficient as possible, it is vital to identify the cell line, media, feed, and resin that best suit your productivity goals.

Learna about the complexities of scaling decisions with insights from biopharma developers and a CDMO. Discover their shared interest in achieving successful scale-up and strategies for avoiding common pitfalls.

We drive innovation and excellence in biologics, offering integrated solutions that help clients efficiently advance their research and successfully bring their products to market.